SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Jul 22, 2013

Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: July 22, 2013 · CIK: 0001430306 · Accession: 0001144204-13-040535

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-188547

Date
July 22, 2013
Author
NATIONAL SECURITIES CORPORATION
Form
CORRESP
Company
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)

Letter

Re: Tonix Pharmaceuticals Holding Corp. (the “Company”)

Roth Capital Partners, LLC National Securities Corporation

888 San Clemente Drive 120 Broadway, 27th Floor

Newport Beach, CA 92660 New York, NY 10271

July 22, 2013

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1 (File No. 333-188547)

Ladies and Gentlemen:

In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 4:00 p.m. (New York Time) on Wednesday, July 24, 2013, or as soon thereafter as practicable.

In making this request the undersigned acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to the registration statement.

Very truly yours,
Roth Capital Partners, LLC
NATIONAL SECURITIES CORPORATION

Show Raw Text
CORRESP
1
filename1.htm

    Roth Capital Partners, LLC
    National Securities Corporation

    888 San Clemente Drive
    120 Broadway, 27th Floor

    Newport Beach, CA  92660
    New York, NY 10271

July 22, 2013

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re:          Tonix Pharmaceuticals Holding
Corp. (the “Company”)

Registration Statement on Form S-1
(File No. 333-188547)

Ladies and Gentlemen:

In connection with the above-captioned
registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned
hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 4:00 p.m. (New
York Time) on Wednesday, July 24, 2013, or as soon thereafter as practicable.

In making this request the undersigned
acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to
the registration statement.

Very truly yours,

    Roth Capital Partners, LLC
    NATIONAL SECURITIES CORPORATION

    By:
    /s/ AARON GUREWITZ

    By:
    /s/ JONATHAN RICH

    Name:
    Aaron Gurewitz

    Name:
    Jonathan Rich

    Title:
    Head of Equity Capital Markets

    Title:
    Head of Investment Banking